This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Oxypharma Ab. Active years: 2009-2011.
Company Filing History:
Years Active: 2009-2011
Title: Ingemar Kihlström: Innovator in Autoimmune Disease Treatment
Introduction
Ingemar Kihlström is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds aimed at treating autoimmune diseases. With a total of 2 patents to his name, Kihlström's work is recognized for its potential impact on medical science.
Latest Patents
Kihlström's latest patents include innovative alkyl substituted indoloquinoxalines. These compounds are characterized by their unique formula and are designed to serve as drugs for preventing and/or treating autoimmune diseases. His research focuses on the therapeutic applications of these novel substituted indoloquinoxalines, showcasing his commitment to advancing healthcare solutions.
Career Highlights
Throughout his career, Kihlström has been associated with Oxypharma AB, where he has played a pivotal role in research and development. His expertise in medicinal chemistry has led to breakthroughs that could change the landscape of treatment for autoimmune conditions. His dedication to innovation is evident in his patent filings and ongoing research efforts.
Collaborations
Kihlström has collaborated with esteemed colleagues such as Ulf Björklund and Jan Bergman. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to more effective solutions in the pharmaceutical industry.
Conclusion
Ingemar Kihlström's contributions to the field of autoimmune disease treatment through his innovative patents and collaborations highlight his role as a key figure in pharmaceutical research. His work continues to inspire advancements in medical science and offers hope for improved therapies.